We developed Ibn AL Baitar with the desire to give back to our community and improve the lives of patients suffering from sicknesses that impair their quality of life.

We began this journey by launching Heberprot-P, a Cuban developed innovative medication for diabetic foot ulcers.

The Medication
In May 2017, we put together an evaluation to show the effectiveness of the medication at the Royal Hospital in Muscat, Oman.

They began by treating 14 very badly wounded patients, with the majority planned for amputation.

However, over two weeks; the wounds had dramatically granulated showing healthy tissues and recovery for all!

Our Website